Cyril Amarchand Mangaldas named ‘Law Firm of the Year – M&A 2018’ by VCCircle

VC Circle Awards 2018 Cyril Amarchand Mangaldas has been named ‘Law Firm of the Year – M&A 2018’ at the VCCircle award function held on Tuesday, 20th August 2018 at The Trident Hotel, Mumbai VCCircle awards now in their seventh year, recognise and felicitate PE- and VC-backed portfolio companies in key sectors, besides [...]

February 20th, 2018|

Cyril Amarchand Mangaldas awarded ‘India: National Law Firm of the Year 2018′ by Chambers & Partners

Cyril Amarchand Mangaldas has been awarded India National Law Firm of the Year 2017 by Chambers & Partners at the Chambers Asia-Pacific Awards 2018 held in Hong Kong on Thursday, February 1st 2018. Chambers & Partners added that Cyril Amarchand Mangaldas remains a favoured choice amongst Indian corporates and financial institutions as well as international [...]

February 3rd, 2018|

Cyril Shroff talks about M&A In 2017 & Outlook For 2018 | Big Deal – CNBC-TV18

‘Nature & composition of public cos is changing dramatically’ Says Top Lawyer Cyril Shroff. Nisha Poddar speaks to Cyril Shroff, Managing Partner at Cyril Amarchand Mangaldas, as he wraps up deal street action for 2017 and discusses cues for the year 2018. Part 1 Source: CNBC-TV18 Part 2 Source: CNBC-TV18 Part [...]

January 2nd, 2018|

CAM appoints David Morley as member of its Strategic Advisory Board

India’s leading full service law firm, Cyril Amarchand Mangaldas, in a move that demonstrates the firm’s ongoing commitment to lead the Indian legal industry has appointed Mr. David Morley as a member of its Strategic Advisory Board with immediate effect. David Morley On August 9, 2015, Cyril Amarchand Mangaldas had announced the constitution [...]

November 27th, 2017|

Cyril Shroff talks about IBC Ordinance | Bloomberg Quint

‘It Might Hurt Genuine Bidders,’ Says Top Lawyer Cyril Shroff On IBC Ordinance While acknowledging the underlying political message to promoters of insolvent companies, Cyril Shroff, top lawyer and managing partner of law firm Cyril Amarchand Mangaldas, said the IBC ordinance may hurt commercial outcomes and needs better drafting. Source: Bloomberg Quint

November 27th, 2017|

Cyril Shroff On Large Corporate Insolvencies, Judicial Capacity And Promoter Resistance

“The bankruptcy process is off to a flying start” says Cyril Shroff, leading lawyer and managing partner of Cyril Amarchand Mangaldas. Shroff is commenting on a decision to refer 12 top corporate defaulters to insolvency and bankruptcy proceedings. Source: Bloomberg Quint

June 15th, 2017|

Cyril Amarchand Mangaldas appoints Komal Gupta as head of Innovation & AI and establishes Innovation Lab

India’s leading full service law firm, Cyril Amarchand Mangaldas, has appointed Komal Gupta as Head of Innovation & Artificial Intelligence, in a move that demonstrates the firm’s ongoing commitment to lead the Indian legal industry’s evolution and transformation – an initiative driven by the managing partner. Innovation has been identified as a key strategic driver [...]

May 6th, 2017|

NCLT dismisses waiver plea filed by Cyrus Mistry-owned firms

Source: Vccircle In a jolt to former Tata group chairman Cyrus Mistry, the National Company Law Tribunal (NCLT) has dismissed a plea filed by two Mistry family-owned investment companies seeking a waiver from the requirement for shareholders’ approval to file a petition against Tata Sons Ltd. On Monday, a division bench of NCLT, comprising Justice [...]

April 18th, 2017|

Mazagon Dock, five public sector units to list

Source: Daily News and Analysis The government has embarked on a move to partially divest stake in six public sector units, four of which are key players in defence sector. With stock markets enjoying heightened valuations, the government is preparing to list a clutch of defence-related state-owned entities including guided missiles maker Bharat Dynamics, naval [...]

April 13th, 2017|

Luthra, CAM, DSK, Khaitan lead on True North acquisition of Religare Health Insurance

Source: Bar and Bench Religare Enterprises Ltd is selling its entire 80% stake in Religare Health Insurance Co to a consortium of investors led by private equity firm True North. This deal values Religare Health Insurance Company Limited at Rs. 1300 crores. Dalmia Group is also one of the investors and part of the consortium. [...]

April 13th, 2017|


This website has been designed only for the purposes of dissemination of basic information on Cyril Amarchand Mangaldas; information which is otherwise available on the internet, various public platforms and social media. Careful attention has been given to ensure that the information provided herein is accurate and up-to-date. However, Cyril Amarchand Mangaldas is not responsible for any reliance that a reader places on such information and shall not be liable for any loss or damage caused due to any inaccuracy in or exclusion of any information, or its interpretation thereof. Reader is advised to confirm the veracity of the same from independent and expert sources.

This website is not an attempt to advertise or solicit clients, and does not seek to create or invite any lawyer-client relationship. The links provided on this website are to facilitate access to basic information on Cyril Amarchand Mangaldas, and, to share the various thought leadership initiatives undertaken by it. The content herein or on such links should not be construed as a legal reference or legal advice. Readers are advised not to act on any information contained herein or on the links and should refer to legal counsels and experts in their respective jurisdictions for further information and to determine its impact.

Cyril Amarchand Mangaldas advises against the use of the communication platform provided on this website for exchange of any confidential, business or politically sensitive information. User is requested to use his or her judgment and exchange of any such information shall be solely at the user’s risk.

Cyril Amarchand Mangaldas uses cookies on its website to improve its usability. This helps us in providing a good user experience and to also help in improving our website. By continuing to use our website without changing your privacy settings, you agree to use our cookies.